Expert Review of Anti-Infective Therapy
ISSN:1478-7210

Expert Review of Anti-Infective Therapy

EXPERT REV ANTI-INFE
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:偏慢,4-8周
新锐分区:医学3区
年发文量:96
影响因子:3.8
JCR分区:Q1

基本信息

抗感染治疗的专家评论(ISSN 1478-7210)提供了关于传染病治疗中的治疗学和诊断学的专家评论。覆盖范围包括抗生素、耐药性、药物治疗、传染病药物、抗菌、抗微生物、抗真菌和抗病毒方法以及诊断检测。
1478-7210SCIE/Scopus收录
3.8
4.4
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
INFECTIOUS DISEASES 传染病学
3区
MICROBIOLOGY 微生物学
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:INFECTIOUS DISEASES
SCIE
Q1
30/137
学科:MICROBIOLOGY
SCIE
Q2
58/163
学科:PHARMACOLOGY & PHARMACY
SCIE
Q2
92/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:INFECTIOUS DISEASES
SCIE
Q2
57/137
学科:MICROBIOLOGY
SCIE
Q2
75/163
学科:PHARMACOLOGY & PHARMACY
SCIE
Q2
141/353
65
96
5%-偏慢,4-8周-医学-药学
5.3%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
43.75%4.03%0.58%
CiteScore:10.70
SJR:1.090
SNIP:1.134
学科类别分区排名百分位
大类:Medicine
小类:Infectious Diseases
Q1
29 / 357
大类:Medicine
小类:Microbiology (medical)
Q1
17 / 148
大类:Medicine
小类:Virology
Q1
11 / 86
大类:Medicine
小类:Microbiology
Q1
24 / 188

期刊高被引文献

The antiviral properties of vitamin C
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1706483
Cardiovascular complications of acute respiratory infections: current research and future directions
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1689817
Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1629288
A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1581063
The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1705156
Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1585242
Improving the rates of Aspergillus detection: an update on current diagnostic strategies
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2018.1558054
Factors determining phage stability/activity: challenges in practical phage application
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1646126
Perspective of community pharmacists about community-based antimicrobial stewardship programs. A multicenter cross-sectional study from China
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1692655
Lefamulin: a promising new pleuromutilin antibiotic in the pipeline
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1554431
Teixobactin: a novel anti-infective agent
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1550357
Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1573670
Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1573669
A cross-sectional study evaluating the knowledge and beliefs about, and the use of antibiotics amongst Malaysian university students
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1581607
Oxfendazole: a promising agent for the treatment and control of helminth infections in humans
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2018.1555241
Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1568239
Accuracy of presepsin in neonatal sepsis: systematic review and meta-analysis
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1584037
Ocular Chlamydia trachomatis infection: elimination with mass drug administration
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1577136
Late-onset sepsis caused by Gram-negative bacteria in very low birth weight infants: a systematic review
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1568871
Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1621168
Developments in the treatment of HCV genotype 3 infection
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1676730
Non-antibiotic therapies for sepsis: an update
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1581606
Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1588112
Cross-programmatic consultation on the role of primary care in the responsible use of medicines and the reduction of antimicrobial resistance
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2018.1563482
How worthwhile is methylene blue as a treatment of malaria?
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1634545
Screening, diagnosis and risks associated with Hepatitis E virus infection
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1613889
Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1640602
HPV DNA detection in urine samples of women: ‘an efficacious and accurate alternative to cervical samples?’
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1668776
Novel approaches to decrease inappropriate ambulatory antibiotic use
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1635455
An interview with Daniel Berman on the Longitude Prize
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1704368
The treatment of melioidosis: is there a role for repurposed drugs? A proposal and review
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2018.1496330
Asymptomatic malaria in the clinical and public health context
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1693259
Management of bacterial skin and skin structure infections with polymicrobial etiology
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1552518
Antimicrobial resistance in Clostridium difficile ribotype 017
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1701436
Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1645007
Staphylococcus aureus nasal decolonization strategies: a review
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1604220
Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1647781
Management and prevention of drug resistant infections in burn patients
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1648208
Supersaturating drug delivery system of fixed drug combination: sulfamethoxazole and trimethoprim
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1675508
Dibothriocephalus nihonkaiensis: an emerging concern in western countries?
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1665028
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1673731
Letter to the editor: ‘Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America’
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1649140
Prevention and treatment of tuberculosis in solid organ transplant recipients
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1704255
Response to `letter to the editor: ‘Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America’´
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1649139
Indian consensus on the management of CRE infection in critically ill patients (ICONIC) — India
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1647103
Quantitative assessment of the activity of antituberculosis drugs and regimens
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1621747
Antimicrobial stewardship in children: more shadows than lights?
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1686355
Individualized antibiotic therapy in the treatment of severe infections
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1696192
Direct-acting antiviral drugs improve the female sexual burden associated with chronic HCV infection
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2019.1682551
A critical review of the relationship between post-transplant atherosclerotic events and cytomegalovirus exposure in kidney transplant recipients
来源期刊:Expert Review of Anti-infective TherapyDOI:10.1080/14787210.2020.1707079

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学3区
INFECTIOUS DISEASES 传染病学
3区
MICROBIOLOGY 微生物学
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
INFECTIOUS DISEASES 传染病学
3区
MICROBIOLOGY 微生物学
3区
PHARMACOLOGY & PHARMACY 药学
3区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
PHARMACOLOGY & PHARMACY 药学
2区
INFECTIOUS DISEASES 传染病学
3区
MICROBIOLOGY 微生物学
3区